Osteoporosis. Benefits will be provided for qualified individuals for reimbursement for scientifically proven bone mass measurement (bone density testing) for the prevention, diagnosis and treatment of osteoporosis for Members meeting Alliant’s criteria. OUTPATIENT SERVICES Outpatient services include facility, ancillary, facility-use, and professional charges when received as an outpatient at a Hospital, Hospital freestanding facility, Retail Health Clinic, or other Provider as determined by Alliant. These facilities may include a non- hospital site or other Provider facility providing surgery, diagnostic, x-rays, laboratory services, therapy, or rehabilitation services. In an effort to manage quality and cost for our members, Alliant reserves the right to establish Preferred or In-Network Providers for certain services. To determine if a Preferred Provider exists, it is the responsibility of the member to verify the in-network status of a Provider. Members may verify network status by visiting our Find-A-Provider tool on XxxxxxxXxxxx.xxx or calling Customer Service at (000) 000-0000. See the Summary of Benefits and Coverage for any applicable Deductible, Coinsurance, Copayment and benefit limitation information. OUTPATIENT SURGERY Hospital outpatient department or Freestanding Ambulatory Facility charges are Covered Services as outlined in the Summary of Benefits and Coverage. In-network and out-of-network cost-sharing apply accordingly OVARIAN CANCER SURVEILLANCE TESTS • Covered Services are provided for at risk women 35 years of age and older. At risk women are defined as: o having a family history: with one or more first or second-degree relatives with ovarian cancer; of clusters of women relatives with breast cancer; of nonpolyposis; colorectal cancer; or o testing positive for BRCA1 or BRCA2 mutations.
Osteoporosis. Benefits will be provided for qualified individuals for reimbursement for scientifically proven bone mass measurement (bone density testing) for the prevention, diagnosis and treatment of osteoporosis for Members meeting Alliant’s criteria. Other Covered Services Your Contract provides Covered Services when the following services are Medically Necessary: Chemotherapy and radioisotope, radiation and nuclear medicine therapy Diagnostic x-ray and laboratory procedures Dressings, when provided by a covered Physician Oxygen, blood and components, and administration Use of operating and treatment rooms and equipment Outpatient Services See the Summary of Benefits and Coverage’s for any applicable Deductible, Coinsurance, Copayment, and benefit limitation information. Outpatient services include facility, ancillary, facility use, and professional charges when given as an outpatient at a Hospital, Hospital freestanding facility, Retail Health Clinic, or other Provider as determined by us. These facilities may include a non-Hospital site providing diagnostic and therapy services, surgery, or rehabilitation, or other Provider facility as determined by us. Outpatient Surgery Hospital outpatient department or Freestanding Ambulatory Facility charges are covered at regular Contract benefits as shown in the Summary of Benefits and Coverage’s. Some procedures require Prior Authorization or prior approval. Ovarian Cancer Surveillance Tests Covered Services are provided for at risk women 35 years of age and older. At risk women are defined as:
Osteoporosis. Coverage is provided for the Medically Necessary diagnosis and treatment of osteoporosis for high-risk Members, including but not limited to Members who: are estrogen-deficient and are at clinical risk for osteoporosis; have vertebral abnormalities, are receiving long-term glucocorticoid (steroid) therapy, have primary hyperparathyroidism, and have a family history of osteoporosis.
Osteoporosis. Osteoporosis is a term derived from the Greek language and directly translated means porous bone, “osteo” meaning bone and “poros” meaning pore [50]. The terminology associated with OP was developed by German pathologists in the nineteenth century, initially to distinguish it from other conditions such as osteomalacia and osteitis fibrosa cystica [11]. In 1941, Xxxxxxxx et al defined OP pathologically ‘as a condition in which there is a lack of bone tissue, but that tissue which remains is fully calcified’ [51]. The current definition of OP originated with a Consensus Development Conference (CDC) in 1999 [52] and was given credibility by a World Health Organisation (WHO) Study Group in 1994 [53]. It defines OP as: ‘A progressive systemic skeletal disease characterised by low bone mass and micro- architectural deterioration of bone tissue, with a consequent increase in bone fragility and susceptibility to fracture’ [42].
Osteoporosis. Coverage for services related to diagnosis, treatment, and appropriate management of osteoporosis including, but not limited to, all Food and Drug Administration approved technologies, including bone mass measurement technologies as deemed Medically Necessary. Outpatient Facility Services Precertification may be required for all outpatient Facility admissions and specific outpatient services, including diagnostic treatment and other services (see the part called GETTING APPROVAL FOR BENEFITS for details). Certain Reconstructive services, wherever performed, require Precertification (see the part called GETTING APPROVAL FOR BENEFITS for details). Your Agreement includes Covered Services in an: • Outpatient Hospital, including ambulatory care and Physician services, • Ambulatory Surgical Center, • Mental Health / Substance Abuse Facility, or • Other approved Facilities Benefits include Facility and related (ancillary) charges, when Medically Necessary, such as: • Surgical rooms and equipment, • Prescription Drugs, including Specialty Drugs dispensed through the Facility, • Anesthesia and anesthesia supplies and services given by the Hospital or other Facility, • Medical and surgical dressings and supplies, casts, and splints, • Diagnostic services, • Therapy services include Physical, Speech and Occupational Therapy Phenylketonuria (PKU) Benefits for the testing and treatment of phenylketonuria (PKU) are paid on the same basis as any other medical condition. Coverage for treatment of PKU shall include those formulas and special food products that are part of a diet prescribed by a licensed Physician and managed by a health care professional in consultation with a Physician who specializes in the treatment of metabolic disease and who participates in or is authorized by Xxxxx. The diet must be deemed Medically Necessary to avert the development of serious physical or mental disabilities or to promote normal development or function as a consequence of PKU.
Osteoporosis. Benefits will be provided for qualified individuals for reimbursement for scientifically proven bone mass measurement (bone density testing) for the prevention, diagnosis and treatment of osteoporosis for Members meeting USPSTFB B criteria. For more information visit: xxxx://xxx.xxxxxxxxxxxxxxxxxxxxxxxxxxxxx.xxx/ Out-of-Pocket Limit See Program Year Out-of-Pocket Maximum.
Osteoporosis. Osteoporosis is a disease characterized by low bone mass and structural deterioration of bone tissue, leading to bone fragility and an increased susceptibility to fractures. It is a common condition among the elderly--both men and women. The disease is estimated to affect 1 in 4 women above age 65, 1 in 2 women above age 80 and 1 in 10 men above age 80. The most common consequence of osteoporosis is greatly increased risk of broken bones, especially in the hip region. Osteoporosis is estimated to be responsible for more than 1.5 million hip, vertebral, wrist and other fractures annually. The disease is relatively expensive to treat. The estimated cost of osteoporosis on the health care system amounts to over $13.8 billion per year. It is estimated that by the year 2020, the cost of hip fractures, which account for the highest percentage of fractures, will increase six-fold in the United States. In the U.S. market, osteoporosis therapeutics revenues grew from $2.4 billion in 1998 to $3.0 billion in 1999. This growth is expected to continue through 2006. Several medicines are available to either slow the onset of, or reverse, bone loss. New therapies currently under development should further boost market expansion once they reach the market and will xxxxxx greater patient compliance and ultimately improve the market penetration rate. We are developing with our collaborators, Novartis and Lilly, two promising medicines for the treatment and prevention of osteoporosis. Salmon Calcitonin Treatment with salmon calcitonin has been shown to maintain bone mineral density in the spine and reduce the risk of new vertebral fractures in post- menopausal women with osteoporosis. It is also used in the treatment of Paget's disease, hypercalcemia of cancer and bone pain. Salmon calcitonin is more potent than human calcitonin and is currently available as an injection or nasal spray. Calcitonin has been shown to be effective in slowing bone loss and increasing bone density in the spine. Calcitonin's major advantages are its lack of serious side effects, excellent long term safety profile and ease of administration. Annual worldwide sales of salmon calcitonin are estimated to be in excess of $600 million. There are also some studies that suggest an analgesic effect. As a result, the nasal spray has been used in the treatment of acute vertebral fracture syndrome because of its positive effect on both increasing bone density and decreasing pain. We have conducted collaborati...
Osteoporosis. Calcium deficiency may occur years after a gastric bypass. This is a difficult to diagnosis to make until weakness of the bones has already developed. Currently it is best to measure calcium levels and the PTH level (parathyroid hormone). I understand that I am expected to take calcium supplements and supplemental Vitamin D for life after this operation. B vitamin deficiencies: Deficiencies in Thiamine, Niacin, B12 and others have been reported. These B vitamin deficiencies are very rare. Some B vitamin deficiencies can cause irreversible neurological damage. All patients are required to take a multivitamin supplement for life after this operation. Sometimes, additional B vitamin supplements are also required. I understand that it is important to be evaluated regularly for vitamin deficiencies after surgery.
Osteoporosis. Disease which causes thinning of the bone that is not commensurate to age. Partner A person who is an Insured Person’s husband or wife, fiancé or fiancée, or any civil or de facto partner with whom the Insured Person has continuously lived during the three months immediately prior to the date of Accident.
Osteoporosis. Frequency, consequences, and risk factors. Archives of Internal Medicine 1996; 156:1399-411.
